Netherlands· NL-f5285bc91f08
Ervebo, oplossing voor injectie
A ebola-impfstoffe product containing levend verzwakt recombinant vesiculair stomatitisvirus (rvsv, 11481 nt indiana stam) bevattend zaire-ebola virus (zebov, kikwit 1995 stam) envelop glycoproteine (gp), geproduceerd in vero cellen, registered in Netherlands by Merck Sharp & Dohme B.V.. The same ATC class is registered in 9 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Ebola-impfstoffe is registered in 9 of 19 countries.
Countries holding a registration under ATC J07BX02 (ebola-impfstoffe), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 6 of them publish a price we can compare per daily dose
Ebola-impfstoffe · ATC J07BX02
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- LEVEND VERZWAKT RECOMBINANT VESICULAIR STOMATITISVIRUS (rVSV, 11481 nt INDIANA STAM) BEVATTEND ZAIRE-EBOLA VIRUS (ZEBOV, KIKWIT 1995 STAM) ENVELOP GLYCOPROTEINE (GP), GEPRODUCEERD IN VERO CELLEN
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Netherlands (NL)
- ATC code
- J07BX02
- ATC class
- Ebola-Impfstoffe
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/19/1392
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BX02
Ebola-impfstoffe, as other registers publish it.
- FinlandErveboMerck Sharp & Dohme B.V.
- DenmarkErveboMerck Sharp & Dohme B.V.
- BelgiumErveboMerck Sharp & Dohme
- IcelandErveboMerck Sharp & Dohme B.V.*
- PolandErveboMerck Sharp & Dohme B.V.
- CzechiaERVEBOMerck Sharp & Dohme B.V., Haarlem
- IrelandErvebo solution for injectionMerck Sharp & Dohme BV,
- SwitzerlandErvebo, InjektionslösungMSD Merck Sharp & Dohme AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/26083ed3-eeef-47e3-991d-eae068ba7e3a GET /v1/drugs/26083ed3-eeef-47e3-991d-eae068ba7e3a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie",
"route": "Intramusculair gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/ervebo-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Ebola Vaccines",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp124647",
"excipients": [
"NATRIUMHYDROXIDE (E 524)",
"RECOMBINANT HUMAAN SERUM ALBUMINE, AFGELEID VAN RIJST",
"TROMETAMOL",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"LEVEND VERZWAKT RECOMBINANT VESICULAIR STOMATITISVIRUS (rVSV, 11481 nt INDIANA STAM) BEVATTEND ZAIRE-EBOLA VIRUS (ZEBOV, KIKWIT 1995 STAM) ENVELOP GLYCOPROTEINE (GP), GEPRODUCEERD IN VERO CELLEN"
],
"leaflet_url": null,
"authorised_at": "2019/11/11",
"procedure_number": "EMEA/H/C/004554",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/19/1392",
"additional_monitoring": "N"
}See everything about ebola-impfstoffe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.